Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study

BACKGROUND: Ocular melanoma is the most common primary intraocular malignancy and has a very poor prognosis once liver metastases occur. The aim of this study was to prospectively assess the efficacy and safety of percutaneous hepatic perfusion with melphalan (M-PHP) using the new second-generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, T. Susanna, Burgmans, Mark C., de Leede, Eleonora M., de Geus-Oei, Lioe-Fee, Boekestijn, Bas, Handgraaf, Henricus J. M., Hilling, Denise E., Lutjeboer, Jacob, Vuijk, Jaap, Martini, Christian H., van Erkel, Arian R., van der Meer, Rutger W., Tijl, Fred G. J., Speetjens, Frank M., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801354/
https://www.ncbi.nlm.nih.gov/pubmed/32761328
http://dx.doi.org/10.1245/s10434-020-08741-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801354/
https://www.ncbi.nlm.nih.gov/pubmed/32761328
http://dx.doi.org/10.1245/s10434-020-08741-x

Ejemplares similares